Senores Pharmaceuticals
SENORES •NSE

Senores Pharmaceuticals

₹1,133.90-85.30 (7.00%)1D
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Create Stock SIPAutomate your investments in this
Overview
Technicals
News
Events

Performance

Today’s low
1,053.40
Today’s high
1,228.00
52 week low
706.00
52 week high
1,599.00
Open price
1,219.20
Previous close
1,219.20
Live volume
23,16,991
Lower circuit
907.20
Upper circuit
1,360.60

Fundamentals

Market Cap
₹5,612Cr
ROE
12.36%
P/E Ratio(TTM)
40.88
EPS(TTM)
29.81
P/B Ratio
5.60
Dividend Yield
0.00%
Industry P/E
37.65
Book Value
217.79
Debt to Equity
0.37
Face Value
10

Financial performance

Quarterly
Yearly
All Financials
SEP '26
₹201Cr
+9.97%
₹36.60Cr
+20.20%
062.5125187.5250
Sep '25
Dec '25
Mar '26
Jun '26
Sep '26
Revenue growthValue
1Y (TTM)+15%
3Y CAGR+159%
Profit growthValue
1Y (TTM)+22%
3Y CAGR+139%

About

Senores Pharmaceuticals Limited manufactures pharmaceutical formulations and active pharmaceutical ingredients (APIs).;
CEO/MD
Swapnil Jatinbhai Shah
Founded in
2017
NSE symbol
SENORES
Industry

Shareholding pattern

Sep '25
Dec '25
Mar '26
Jun '26
Sep '26
Shareholder details

Mutual Funds Invested (4)

Similar stocks

StockMkt price (1D)52 week performanceMarket capP/E ratioP/B ratio
₹2,325.60
-50.50 (2.13%)
L
    H
    18,042.1426.615.35
    PfizerPFIZER
    ₹3,687.80
    -72.00 (1.91%)
    L
      H
      17,202.9823.44.09
      ₹6,364.50
      +65.50 (1.04%)
      L
        H
        15,745.1392.8218.04
        Natco PharmaNATCOPHARM
        ₹782.40
        -5.15 (0.65%)
        L
          H
          15,453.1313.51.47
          Livesquawk •
          Senores Pharma expects 13 ANDAs with 41 strengths to be commercialized in the government channel in H2FY27.
          Livesquawk •
          Senores Pharmaceuticals approved a ₹43 crore expansion plan for its subsidiaries. The project includes a new prefilled syringe manufacturing line, with completion expected by March 2027.
          Livesquawk •
          Senores reported Q2 consolidated net profit of 390M rupees, up from 330M rupees YoY.
          2026
          29
          Oct
          Quarterly Result
          Release date
          27
          Jul
          Quarterly Result
          Release date
          14
          May
          Annual Result
          Release date
          20
          Jan
          Quarterly Result
          Release date
          2025
          6
          Nov
          Quarterly Result
          Release date
          23
          Jul
          Quarterly Result
          Release date
          Events calendar
          View upcoming events in other stocks